Huiping Shi

机构：Beijing Institute of Technology, Jinling Institute of Technology · ORCID：0000-0002-4727-9999

发表论文 76 篇 · 总被引 1131 次 · h-index 21

代表论文

• Targeted reprogramming of tumor-associated macrophages for overcoming glioblastoma resistance to chemotherapy and immunotherapy (2024 · Biomaterials · 被引 56)
• L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus (2021 · JCI Insight · 被引 49)
• Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently? (2022 · Frontiers in Immunology · 被引 43)
• LFA-1 Activation in T-Cell Migration and Immunological Synapse Formation (2023 · Cells · 被引 30)
• Slc35a1 deficiency causes thrombocytopenia due to impaired megakaryocytopoiesis and excessive platelet clearance in the liver (2020 · Haematologica · 被引 30)
• Aptamers targeting SARS-CoV-2 nucleocapsid protein exhibit potential anti pan-coronavirus activity (2024 · Signal Transduction and Targeted Therapy · 被引 28)